Shanghai Fosun Pharmaceutical to issue up to RMB 4 billion notes

By William Gullotti

Buffalo, N.Y., Aug. 19 – Shanghai Fosun Pharmaceutical (Group) Co., Ltd. received regulatory approval to issue up to RMB 4 billion of medium-term notes, according to an announcement on Friday.

The notes will be issued in tranches within 24 months, with the approval period starting Aug. 12.

China Merchants Bank Co., Ltd. and Bank of Shanghai Co., Ltd. are the joint lead underwriters.

The pharmaceutical company is a Shanghai-based member of the Hong Kong group Fosun International Ltd.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.